1. Home
  2. ZURA vs VPG Comparison

ZURA vs VPG Comparison

Compare ZURA & VPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • VPG
  • Stock Information
  • Founded
  • ZURA 2022
  • VPG 2009
  • Country
  • ZURA United States
  • VPG United States
  • Employees
  • ZURA N/A
  • VPG N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • VPG Electrical Products
  • Sector
  • ZURA Health Care
  • VPG Technology
  • Exchange
  • ZURA Nasdaq
  • VPG Nasdaq
  • Market Cap
  • ZURA 69.9M
  • VPG 340.4M
  • IPO Year
  • ZURA N/A
  • VPG N/A
  • Fundamental
  • Price
  • ZURA $1.13
  • VPG $29.58
  • Analyst Decision
  • ZURA Buy
  • VPG Hold
  • Analyst Count
  • ZURA 7
  • VPG 1
  • Target Price
  • ZURA $14.33
  • VPG $31.00
  • AVG Volume (30 Days)
  • ZURA 709.5K
  • VPG 151.5K
  • Earning Date
  • ZURA 08-08-2025
  • VPG 08-05-2025
  • Dividend Yield
  • ZURA N/A
  • VPG N/A
  • EPS Growth
  • ZURA N/A
  • VPG N/A
  • EPS
  • ZURA N/A
  • VPG 0.23
  • Revenue
  • ZURA N/A
  • VPG $297,480,000.00
  • Revenue This Year
  • ZURA N/A
  • VPG N/A
  • Revenue Next Year
  • ZURA N/A
  • VPG $6.38
  • P/E Ratio
  • ZURA N/A
  • VPG $129.24
  • Revenue Growth
  • ZURA N/A
  • VPG N/A
  • 52 Week Low
  • ZURA $0.97
  • VPG $18.57
  • 52 Week High
  • ZURA $5.07
  • VPG $35.11
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 48.73
  • VPG 67.01
  • Support Level
  • ZURA $1.00
  • VPG $26.99
  • Resistance Level
  • ZURA $1.22
  • VPG $28.56
  • Average True Range (ATR)
  • ZURA 0.08
  • VPG 1.12
  • MACD
  • ZURA -0.00
  • VPG 0.25
  • Stochastic Oscillator
  • ZURA 52.00
  • VPG 94.90

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About VPG Vishay Precision Group Inc.

Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.

Share on Social Networks: